Burlington-based Labcorp has launched the first blood-based test cleared by the U.S. Food and Drug Administration (FDA) for aiding in the diagnosis of Alzheimer's disease.
Few studies examine how severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) tests assist or hinder efforts to prevent illness, hospitalisations, or people dying. Due to weak evidence, we’re ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback